Amgicin 200 Gemcitabine Injection IP 200 Mg About
Amgicin 200 Gemcitabine Injection IP 200 Mg is a highlighted, masterful solution in oncology care, designed with sublime precision for intravenous infusion. Customizable to patient needs, each sterile, single-use vial contains 200 mg lyophilized Gemcitabine, offering ravishing results in the treatment of pancreatic, breast, ovarian, and non-small cell lung cancers. Marketed internationally, Amgicin 200 is crafted to supreme standards, providing a special rate on quality therapy. With careful compatibility instructions and a premium shelf life, it embodies sophisticated excellence in cancer management.
Comprehensive Oncology Applications
Amgicin 200 Gemcitabine Injection IP 200 Mg is specifically formulated for use in hospital and clinical oncology settings. The solution is designed for intravenous application, targeting a broad area of malignant conditions such as pancreatic, breast, ovarian, and non-small cell lung cancers. Its clear, colorless to light straw-colored composition ensures precise administration, making it ideal for professional medical environments where accuracy is paramount in cancer treatment.
Supply, Packaging, and Delivery Details
Amgicin 200 Gemcitabine Injection IP 200 Mg is charged and handed over in secure, single-use vials, meticulously packaged in individual boxes for optimal protection. The product is supplied with a robust ability to meet substantial hospital and clinical demands internationally. FOB Port services are efficiently organized, ensuring prompt delivery and smooth handling right from the point of origin to medical facilities worldwide.
FAQ's of Amgicin 200 Gemcitabine Injection IP 200 Mg:
Q: How should Amgicin 200 Gemcitabine Injection be administered for optimal results?
A: Amgicin 200 is administered as an intravenous infusion after proper dilution with the recommended diluent. The procedure should be performed by trained healthcare professionals in a hospital or clinical setting.
Q: What cancers is Amgicin 200 primarily indicated to treat?
A: Amgicin 200 Gemcitabine Injection is used in the treatment of various cancers, including pancreatic cancer, breast cancer, ovarian cancer, and non-small cell lung cancer.
Q: When is Amgicin 200 contraindicated?
A: Amgicin 200 is contraindicated in patients with a known hypersensitivity to gemcitabine or any of its components. It should not be used in individuals with such allergies.
Q: Where should Amgicin 200 be stored to maintain efficacy?
A: This injection should be stored below 25C and protected from light to preserve its potency and ensure a full shelf life of up to 24 months.
Q: What are the key precautions and potential adverse effects to consider?
A: Use Amgicin 200 with caution in patients with renal or hepatic impairment. Possible adverse effects include myelosuppression, nausea, vomiting, rash, and fever.
Q: How does the packaging of Amgicin 200 ensure safety and quality?
A: Each sterile, single-use vial is packaged individually in a box, ensuring both safety and precise dosing for every patient in hospital and clinical settings.